Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?
- 30 November 1986
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (11) , 1289-1293
- https://doi.org/10.1016/0277-5379(86)90135-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancerCancer, 1985
- The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 casesCancer, 1984
- High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.Journal of Clinical Oncology, 1984
- Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group studyCancer, 1984
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISPublished by Elsevier ,1979
- Combination chemotherapy in germinal cell tumorsCancer Treatment Reviews, 1976